President
CurrentPiomic Medical, headquartered in Zurich, Switzerland with a U.S. subsidiary in Chicago, is a medtech startup and pioneer in the development of innovative medical devices for the treatment of chronic and acute wounds.In late 2022 the U.S. Food and Drug Administration (FDA) fully approved Piomic’s Investigational Device Exemption (IDE) application for.